176 related articles for article (PubMed ID: 9368613)
1. MUC1 peptide epitopes associated with five different H-2 class I molecules.
Apostolopoulos V; Haurum JS; McKenzie IF
Eur J Immunol; 1997 Oct; 27(10):2579-87. PubMed ID: 9368613
[TBL] [Abstract][Full Text] [Related]
2. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
Shirai M; Pendleton CD; Berzofsky JA
J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
[TBL] [Abstract][Full Text] [Related]
3. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
[TBL] [Abstract][Full Text] [Related]
4. CTL in mice immunized with human mucin 1 are MHC-restricted.
Apostolopoulos V; Loveland BE; Pietersz GA; McKenzie IF
J Immunol; 1995 Dec; 155(11):5089-94. PubMed ID: 7594517
[TBL] [Abstract][Full Text] [Related]
5. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.
Pisarev VM; Kinarsky L; Caffrey T; Hanisch FG; Sanderson S; Hollingsworth MA; Sherman S
Int Immunopharmacol; 2005 Feb; 5(2):315-30. PubMed ID: 15652762
[TBL] [Abstract][Full Text] [Related]
6. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
Lipford GB; Hoffman M; Wagner H; Heeg K
J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
[TBL] [Abstract][Full Text] [Related]
7. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
[TBL] [Abstract][Full Text] [Related]
8. Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen.
Apostolopoulos V; Karanikas V; Haurum JS; McKenzie IF
J Immunol; 1997 Dec; 159(11):5211-8. PubMed ID: 9548459
[TBL] [Abstract][Full Text] [Related]
9. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
Zügel U; Schoel B; Kaufmann SH
J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
[TBL] [Abstract][Full Text] [Related]
10. Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1.
Magarian-Blander J; Ciborowski P; Hsia S; Watkins SC; Finn OJ
J Immunol; 1998 Apr; 160(7):3111-20. PubMed ID: 9531265
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated E6 protein of human papillomavirus type 16 contains an unusual H-2Kb-restricted cytotoxic T cell epitope.
Gao L; Walter J; Travers P; Stauss H; Chain BM
J Immunol; 1995 Dec; 155(12):5519-26. PubMed ID: 7499833
[TBL] [Abstract][Full Text] [Related]
12. Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells.
Abdel-Motal UM; Berg L; Rosén A; Bengtsson M; Thorpe CJ; Kihlberg J; Dahmén J; Magnusson G; Karlsson KA; Jondal M
Eur J Immunol; 1996 Mar; 26(3):544-51. PubMed ID: 8605919
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
[TBL] [Abstract][Full Text] [Related]
14. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells.
Bellone M; Iezzi G; Manfredi AA; Protti MP; Dellabona P; Casorati G; Rugarli C
Eur J Immunol; 1994 Nov; 24(11):2691-8. PubMed ID: 7525300
[TBL] [Abstract][Full Text] [Related]
15. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.
Bristol JA; Schlom J; Abrams SI
J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class I allele-specific peptide libraries: identification of peptides that mimic an H-Y T cell epitope.
Gavin MA; Dere B; Grandea AG; Hogquist KA; Bevan MJ
Eur J Immunol; 1994 Sep; 24(9):2124-33. PubMed ID: 7522161
[TBL] [Abstract][Full Text] [Related]
17. Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells.
Hiltbold EM; Alter MD; Ciborowski P; Finn OJ
Cell Immunol; 1999 Jun; 194(2):143-9. PubMed ID: 10383817
[TBL] [Abstract][Full Text] [Related]
18. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
19. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
[TBL] [Abstract][Full Text] [Related]
20. A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen.
Kuhröber A; Schirmbeck R; Reimann J
Immunology; 1994 Dec; 83(4):532-9. PubMed ID: 7533132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
